;is disclosed. L1, L2, L3, L4, and L5 may be or include independently metal-coordinating ligands selected from the group consisting of neutral ligands, anionic ligands, and mixed ligands, and combinations thereof. In a non-limiting embodiment, the complex is an N-heterocyclic carbene (NHC) Re(I) complex having an unsubstituted or substituted benzimidazol-2-ylidene ligand. The complex may be included in a pharmaceutical composition for treating gram (+) bacterial infections."/>
公开/公告号US2020199162A1
专利类型
公开/公告日2020-06-25
原文格式PDF
申请/专利权人 RUHR-UNIVERSITAET BOCHUM;
申请/专利号US201816629044
申请日2018-06-18
分类号C07F13;G01N33/544;
国家 US
入库时间 2022-08-21 11:24:23